Researchers find experimental drug can help fight debilitating side effect of ovarian cancer

Women who have ovarian cancer often develop a condition called ascites, which is a buildup of fluids in the abdomen. A drug that inhibits a receptor called the Colony-Stimulating-Factor-1 Receptor, or CSF1R, reduces ascites with minimal side effects, new research shows. —> Read More